Effect of upadacitinib on atopic hand eczema in patients with moderate‐to‐severe atopic dermatitis: Results from two randomized phase 3 trials
E. Simpson, K. Rahawi, X. Hu, A. Chu, C. Nduaka, S. Jazayeri, P. Lio, C. Lynde, M. Schuttelaar, Celgene Cipher Genentech GlenMark Incyte Myers Squibb, Leo Janssen, Kyowa Pfizer Merck Pharma, M. Schuttelaar, E. Simpson
Journal of the European Academy of Dermatology and Venereology